As co-chair of the firm's Life Sciences group, Bradford Addison has successfully prosecuted more than 10,000 original and complex patents over the course of his career. With a Ph.D. in pharmacology, Brad understands even the most cutting-edge science and technology behind innovation, as well as how to realize the true value of a commercially viable patent.
Brad prepares and prosecutes patent applications in the chemical and biotech areas, including pharmaceuticals, molecular biology, instrumental analysis, tissue graft compositions, antiviral agents, immunoassay technology, polymer chemistry and combinatorial chemistry techniques. Brad works diligently with clients to design and execute patent portfolios that consider and incorporate the longer term commercial objectives for patent monetization.
Brad’s objective is to ultimately identify and write patents that are distinct and can be licensed and enforced. His in-depth experience in patent preparation and prosecution benefits entrepreneurs and emerging companies, major corporations, industry leaders and thought innovators, as well as universities and research institutions. Clients and colleagues alike appreciate that Brad delivers pragmatic, comprehensive counsel and excellent work product.
In addition to analyzing invention disclosures and preparing and filing patent applications, Brad advises on and coordinates global patent prosecution initiatives. He also represents clients in administrative appeals, petitions and protests, as well as advocates client positions in post grant reviews, re-examinations and reissues.
A member of the American Intellectual Property Law Association, Brad is particularly effective in working productively with patent examiners. His strong technical background and practical experience over decades of practice allow him to speak the language of clients and examiners alike, which often streamlines the patent process and aids in successful prosecution efforts.